Torthaí cuardaigh - Robert, Flisiak
- 1 - 20 toradh as 67 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Role of cannabinoids in chronic liver diseases de réir Anna Parfieniuk‐Kowerda, Robert Flisiak
Foilsithe / Cruthaithe 2008Revisão -
2
Thrombotic Thrombocytopenia after COVID-19 Vaccination: In Search of the Underlying Mechanism de réir Piotr Rzymski, Bartłomiej Perek, Robert Flisiak
Foilsithe / Cruthaithe 2021Revisão -
3
Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C de réir Anatol, Panasiuk, Robert, Flisiak, Danuta, Prokopowicz
Foilsithe / Cruthaithe 2005Téacs -
4
Hepatitis C: efficacy and safety in real life de réir Robert Flisiak, Joanna Pogorzelska, Marta Flisiak‐Jackiewicz
Foilsithe / Cruthaithe 2017Revisão -
5
The Role of Th17 Response in COVID-19 de réir Diana Martonik, Anna Parfieniuk‐Kowerda, Magdalena Rogalska, Robert Flisiak
Foilsithe / Cruthaithe 2021Revisão -
6
The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins de réir Lech Chrostek, Łukasz Supronowicz, Anatol Panasiuk, Bogdan Cylwik, Ewa Gruszewska, Robert Flisiak
Foilsithe / Cruthaithe 2013Artigo -
7
Helicobacter pylori infection among patients with liver cirrhosis de réir Joanna Pogorzelska, Magda Łapińska, Alicja Kalinowska-Łyszczarz, Tadeusz Wojciech Łapiński, Robert Flisiak
Foilsithe / Cruthaithe 2017Artigo -
8
Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C de réir Michał Brzdęk, Dorota Zarębska‐Michaluk, Federica Invernizzi, Marta Cilla, Krystyna Dobrowolska, Robert Flisiak
Foilsithe / Cruthaithe 2023Revisão -
9
Recommendations for the treatment of hepatitis C in 2017 de réir Waldemar Halota, Robert Flisiak, Jacek Juszczyk, Piotr Małkowski, Małgorzata Pawłowska, Krzysztof Simon, Krzysztof Tomasiewicz
Foilsithe / Cruthaithe 2017Revisão -
10
-
11
Hyaluronic acid concentration in liver diseases de réir Monika Gudowska-Sawczuk, Ewa Gruszewska, Anatol Panasiuk, Bogdan Cylwik, Robert Flisiak, Magdalena Świderska, Maciej Szmitkowski, Lech Chrostek
Foilsithe / Cruthaithe 2015Artigo -
12
Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023 de réir Krzysztof Tomasiewicz, Robert Flisiak, Jerzy Jaroszewicz, Piotr Małkowski, Małgorzata Pawłowska, Anna Piekarska, Krzysztof Simon, Dorota Zarębska‐Michaluk
Foilsithe / Cruthaithe 2023Revisão -
13
A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C de réir Robert Flisiak, Mitchell L. Shiffman, Juan Arenas, Hugo Cheinquer, И. Г. Никитин, Yuping Dong, Khurram Rana, Subasree Srinivasan
Foilsithe / Cruthaithe 2016Artigo -
14
Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists de réir Robert Flisiak, Andrzej Horban, Jerzy Jaroszewicz, Dorota Kozielewicz, Małgorzata Pawłowska, Miłosz Parczewski, Anna Piekarska, Krzysztof Tomasiewicz, Dorota Zarębska‐Michaluk
Foilsithe / Cruthaithe 2020Artigo -
15
Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020 de réir Robert Flisiak, Andrzej Horban, Jerzy Jaroszewicz, Dorota Kozielewicz, Małgorzata Pawłowska, Miłosz Parczewski, Anna Piekarska, Krzysztof Simon, Krzysztof Tomasiewicz, Dorota Zarębska‐Michaluk
Foilsithe / Cruthaithe 2020Artigo -
16
Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020 de réir Robert Flisiak, Miłosz Parczewski, Andrzej Horban, Jerzy Jaroszewicz, Dorota Kozielewicz, Małgorzata Pawłowska, Anna Piekarska, Krzysztof Simon, Krzysztof Tomasiewicz, Dorota Zarębska‐Michaluk
Foilsithe / Cruthaithe 2020Artigo -
17
Clinical Characteristics of Hospitalized COVID-19 Patients Who Received at Least One Dose of COVID-19 Vaccine de réir Piotr Rzymski, Monika Pazgan‐Simon, Krzysztof Simon, Tadeusz Wojciech Łapiński, Dorota Zarębska‐Michaluk, Barbara Szczepańska, Michał Chojnicki, Iwona Mozer‐Lisewska, Robert Flisiak
Foilsithe / Cruthaithe 2021Artigo -
18
Acylcarnitine and Free Fatty Acid Profiles in Primary Biliary Cholangitis: Associations with Fibrosis and Inflammation de réir Magdalena Rogalska, Agnieszka Błachnio‐Zabielska, Piotr Zabielski, J Janica, Kamila Roszczyc-Owsiejczuk, Karolina Pogodzińska, Aleksandra Andrzejuk, A Dâbrowski, Robert Flisiak, Paweł Rogalski
Foilsithe / Cruthaithe 2025Artigo -
19
Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe de réir Vincent Soriano, Amanda Mocroft, Lars Peters, JK Rockstroh, Francisco Antunes, Nikolai Kirkby, Stéphane De Wit, A. D’Arminio Monforte, Robert Flisiak, Jens Lundgren
Foilsithe / Cruthaithe 2010Artigo -
20
Management of SARS-CoV-2 Infection-Clinical Practice Guidelines of the Polish Association of Epidemiologists and Infectiologists, for 2025 de réir Robert Flisiak, Jerzy Jaroszewicz, Dorota Kozielewicz, Ernest Kuchar, Miłosz Parczewski, Małgorzata Pawłowska, Anna Piekarska, Piotr Rzymski, Krzysztof Simon, Krzysztof Tomasiewicz, Dorota Zarębska‐Michaluk
Foilsithe / Cruthaithe 2025Revisão
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Virus
Virology
Immunology
Gastroenterology
Disease
Hepatitis C virus
Infectious disease (medical specialty)
Coronavirus disease 2019 (COVID-19)
Ribavirin
Biology
Hepatitis C
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Adverse effect
Hepatitis B virus
Pathology
Cirrhosis
HBsAg
Hepatitis B
2019-20 coronavirus outbreak
Chronic hepatitis
Gene
Outbreak
Pandemic
Viral load
Environmental health
HBeAg
Human immunodeficiency virus (HIV)
Intensive care medicine